Difference between revisions of "Template:Anticholinergics"

From blackwiki
Jump to navigation Jump to search
blackwiki>Arcadian
(grouping)
blackwiki>Arcadian
(grouping, Vesamicol)
Line 9: Line 9:
  
 
   | group1 = [[Ganglionic blocker|Ganglionic]]
 
   | group1 = [[Ganglionic blocker|Ganglionic]]
   |  list1 = ''nondepolarizing'' ([[Mecamylamine]], [[Trimetaphan camsilate|Trimetaphan]], [[Hexamethonium]]){{·}} [[Nicotine|Nicotine (high doses)]]
+
   |  list1 = ''nondepolarizing'' ([[Mecamylamine]], [[Trimetaphan camsilate|Trimetaphan]], [[Hexamethonium]]){{·}} [[Nicotine|Nicotine (high doses)]]<BR>''note: in [[Parasympathetic nervous system|PNS]], ganglionic blocker can have direct '''antinicotinic''' action at [[Preganglionic fibers|preganglionic]] terminal, but simulate indirect '''antimuscarinic''' activities at [[Postganglionic fibers|postganglionic]] terminal
  
 
   | group2 = [[Neuromuscular blocker|Neuromuscular]]
 
   | group2 = [[Neuromuscular blocker|Neuromuscular]]
Line 44: Line 44:
 
}}
 
}}
 
| group2 = [[Muscarinic antagonist]]s
 
| group2 = [[Muscarinic antagonist]]s
|  list2 = ''nonpolar/tertiary/[[Blood-brain barrier|CNS]]:'' [[Atropine]]{{·}} [[Scopolamine]]
+
|  list2 = ''nonpolar/tertiary/[[Blood-brain barrier|CNS]]:'' [[Atropine]]{{·}} [[Scopolamine]]{{·}} ''[[antiparkinson drug]]s'' ([[Benzatropine]], [[Trihexyphenidyl]], [[Biperiden]])
  
''polar/quarternary/non-CNS:'' [[Muscarinic acetylcholine receptor M1|M1]] ([[Pirenzepine]]){{·}} [[Muscarinic acetylcholine receptor M3|M3]] ([[Tiotropium]], [[Darifenacin]])
+
''polar/quarternary/non-CNS:'' [[Glycopyrrolate]]{{·}} [[Ipratropium]]{{·}} [[Muscarinic acetylcholine receptor M1|M1]] ([[Pirenzepine]]){{·}} [[Muscarinic acetylcholine receptor M3|M3]] ([[Tiotropium]], [[Darifenacin]])
  
''unsorted:'' [[Ipratropium]]{{·}} [[Tropicamide]]{{·}} [[Cyclopentolate]]{{·}} [[Dicycloverine]]{{·}} [[Tolterodine]]{{·}} [[Oxybutynin]]{{·}} [[Homatropine]]{{·}} ''[[antiparkinson drug]]s'' ([[Benzatropine]], [[Trihexyphenidyl]], [[Biperiden]])
+
''unsorted:'' [[Tropicamide]]{{·}} [[Cyclopentolate]]{{·}} [[Dicycloverine]]{{·}} [[Tolterodine]]{{·}} [[Oxybutynin]]{{·}} [[Homatropine]]
  
| group3 = Presynaptic
+
| group3 = Indirect
|  list3 = ''acetylcholine synthesis inhibitor'' ([[Hemicholinium-3]]){{·}} ''acetylcholine release inhibitor'' ([[Botulinum toxin]]) - ''acetylcholine release stimulator'' ([[Alpha-latrotoxin]])
+
|  list3 = ''acetylcholine synthesis inhibitor'' ([[Hemicholinium-3]]){{·}} ''vesicle storage inhibitor'' ([[Vesamicol]]){{·}} ''acetylcholine release inhibitor'' ([[Botulinum toxin]]){{·}}''acetylcholine release stimulator'' ([[Alpha-latrotoxin]]){{·}} ''acetylcholinesterase reactivators'' ([[Pralidoxime]], [[Obidoxime]])
  
| group4 = Other
+
| group4 =  
|  list4 = ''acetylcholinesterase reactivators'' ([[Pralidoxime]], [[Obidoxime]])
+
|  list4 =  
 
 
| group5 =
 
|  list5 = ''note: in [[Parasympathetic nervous system|PNS]], ganglionic blocker can have direct '''antinicotinic''' action at [[Preganglionic fibers|preganglionic]] terminal, but simulate indirect '''antimuscarinic''' activities at [[Postganglionic fibers|postganglionic]] terminal
 
  
 
}}<noinclude>[[Category:Drug templates|{{PAGENAME}}]]</noinclude>
 
}}<noinclude>[[Category:Drug templates|{{PAGENAME}}]]</noinclude>

Revision as of 20:16, 4 October 2008